In-Depth Chat with Antonio Ciaccia, Renowned PBM Industry Watchdog: Insights and Tips To Successfully Navigate the New PBM Landscape
September 24, 2024 | 2 PM ET
Antonio Ciaccia, a prominent pharmacy industry leader and President of 3 Axis Advisors, joins US-Rx Care’s CEO, Renzo Luzzatti, in this exclusive webinar offering employers and benefits advisors:
- Insights into recent industry litigation and the implications for employers and benefits advisors
- Key findings from recent governmental investigations into the PBM industry
- Crucial steps for meeting new requirements and mitigating corporate liability for large employers
- Takeaways from Antonio’s extensive research on PBM pricing and the impacts of conflicts of interest
Register for the Webinar
Featured Speakers
Antonio Ciaccia
President of 3 Axis Advisors
CEO and Co-Founder of 46brooklyn Research
Born and raised in the world of pharmacy, Antonio Ciaccia has been crawling around pharmacies his entire life. After three years as a pharmacy technician and two years of pre-pharmacy curriculum, Antonio diverted course, graduating from The Ohio State University in 2007 with dual degrees in communications and political science before moving into the world of association management, eventually heading up government affairs for the Ohio Pharmacists Association, where his data analytics work helped lead state officials to audit and uncover $244 million in hidden prescription drug overcharges in the state Medicaid managed care program.
After years of studying the pharmacy marketplace, Antonio became increasingly perplexed and concerned as he saw drug costs spiking while payouts to pharmacies were declining and more drugs were being excluded from plan coverage. Knowing something was being lost somewhere in the middle of an ever-growing transaction, Antonio has spent years working to crack the drug pricing code and pull the rug out from what he believes is one of the most dysfunctional marketplaces in the world.
Today, he serves as the President of 3 Axis Advisors, a consulting firm that works with fraud investigators, state attorneys general, provider groups, research firms, technology companies, law firms, investment analysts, employers, government agencies, benefit consultants, and health plans to diagnose and eliminate inefficiencies and inappropriate incentives in the prescription drug supply chain. He is also the CEO and co-founder of 46brooklyn Research, a nonprofit organization dedicated to improving the transparency and accessibility of drug pricing data for the American public.
Moderator: Renzo Luzzatti | President
US-Rx Care
Renzo has over 25 years experience in the healthcare industry with a primary focus in managed care, pharmacy, and pharmacy benefits. His healthcare career has included management roles in almost every facet of the pharmacy world from drug development, manufacturing, and marketing to dispensing and care delivery as well as pharmacy benefit risk management. He co-founded US-Rx Care in 2007 to address identified service and efficiency gaps in the pharmacy benefit marketplace. US-Rx Care has since become a valued, reliable business partner to benefits management firms, health plans, and self-funded employers large and small.